Envista Holdings (NVST) Total Non-Current Liabilities (2018 - 2026)
Envista Holdings (NVST) posted quarterly Total Non-Current Liabilities of $5.4 billion for Q2 2026, up 1.84% year-over-year from $5.3 billion in Q2 2025, and down 1.83% quarter-over-quarter from $5.5 billion in Q4 2025.
Envista Holdings (NVST) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Envista Holdings' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $5.4 billion for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 1.84% year-over-year to $5.4 billion; the TTM figure through Apr 2026 stood at $5.4 billion (up 1.84% YoY), while the FY2025 annual figure was $5.5 billion, up 5.89% from the prior year.
- Total Non-Current Liabilities for Q2 2026 stood at $5.4 billion, down from $5.5 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $6.5 billion in Q3 2023, with the low at $5.2 billion in Q4 2024.
- The 5-year median for Total Non-Current Liabilities is $6.2 billion (2022), against an average of $5.9 billion.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities gained 6.18% in 2022, then fell 19.37% in 2024.
- Envista Holdings' Total Non-Current Liabilities stood at $6.4 billion in 2022, then rose by 0.42% to $6.5 billion in 2023, then dropped by 19.37% to $5.2 billion in 2024, then climbed by 5.89% to $5.5 billion in 2025, then slipped by 1.83% to $5.4 billion in 2026.
- Business Quant data shows NVST's Total Non-Current Liabilities at $5.4 billion in Q2 2026, $5.5 billion in Q4 2025, and $5.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.48 Bn | 128.26 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.15 Bn | 51.29 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.59 Bn | 34.24 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.67 Bn | 32.20 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 28.56 Bn | 25.88 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.34 Bn | 14.94 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.59 Bn | 11.44 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Envista Holdings | 4.35 Bn | 3.23 Bn | 407.00 Mn | 5.43 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 5.43 Bn |
| Apr 3, 2026 | 5.42 Bn |
| Dec 31, 2025 | 5.52 Bn |
| Sep 26, 2025 | 5.47 Bn |
| Jun 27, 2025 | 5.49 Bn |
| Mar 28, 2025 | 5.32 Bn |
| Dec 31, 2024 | 5.21 Bn |
| Sep 27, 2024 | 5.36 Bn |
| Jun 28, 2024 | 5.29 Bn |
| Mar 29, 2024 | 6.42 Bn |
| Dec 31, 2023 | 6.46 Bn |
| Sep 29, 2023 | 6.53 Bn |
| Jun 30, 2023 | 6.45 Bn |
| Mar 31, 2023 | 6.42 Bn |
| Dec 31, 2022 | 6.44 Bn |
| Sep 30, 2022 | 6.19 Bn |
| Jul 1, 2022 | 6.26 Bn |
| Apr 1, 2022 | 6.28 Bn |
| Dec 31, 2021 | 6.27 Bn |
| Oct 1, 2021 | 6.24 Bn |